Home
Conditions
Pulmonary Fibrosis

Clinical trial condition

Pulmonary Fibrosis

Explore clinical trials studying Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

234 public trials 58 recruiting studies

Refine in advanced search Browse all conditions

Pulmonary Fibrosis trial results

Active, Not Recruiting

Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis

NCT07396467

Conditions: Disease, Fibrosis, Interstitial Lung Diseases, +12 more
Locations: The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Active, Not Recruiting

A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

NCT06422884

Conditions: Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +6 more
Locations: Research Site Quilmes, Buenos Aires, Argentina

Research Site Buenos Aires, Argentina

Research Site Buenos Aires, Argentina

Research Site Mendoza, Argentina

View all 78 locations

View Trial Details

Active, Not Recruiting

Atezolizumab for Idiopathic Pulmonary Fibrosis

NCT05515627

Conditions: Fibrosis, Idiopathic Interstitial Pneumonias, Idiopathic Pulmonary Fibrosis, +6 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

Pulmonary Fibrosis During Severe COVID-19 Pneumonia

NCT04987528

Conditions: Acute Respiratory Distress Syndrome, Fibrosis, Lung Diseases, +8 more
Locations: Hopital Europeen Marseille Marseille, France

View Trial Details

Active, Not Recruiting

Post Acute Sequelae of COVID-19

NCT04964115

Conditions: COVID-19, COVID-19 Acute Respiratory Distress Syndrome, Coronaviridae Infections, +18 more
Locations: Vanderbilt_University MC Nashville, Tennessee, United States

View Trial Details

Active, Not Recruiting

The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib

NCT06912659

Conditions: Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +4 more
Locations: Evidenze Health Espana S.L. Barcelona, Spain

View Trial Details

Active, Not Recruiting

Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis

NCT04948203

Conditions: COVID-19, COVID-19 Pneumonia, Chronic Disease, +20 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Active, Not Recruiting

Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)

NCT00258544

Conditions: Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +4 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT05321420

Conditions: Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +6 more
Locations: University of Alabama Birmingham Birmingham, Alabama, United States

Science 37 Los Angeles, California, United States

NewportNativeMD, Inc. Newport Beach, California, United States

Paradigm Clinical Research Centers, Inc. Redding, California, United States

View all 103 locations

View Trial Details

Active, Not Recruiting

Clinical Study of Allogeneic Fat Decellularized Active Protein in the Treatment of Pulmonary Fibrosis

NCT05883293

Conditions: Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +4 more
Locations: The Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Pulmonary Fibrosis

Pulmonary Fibrosis trial results

Related conditions